Surety: BioPharma

“If you aren’t ready to prove the authenticity of your electronic records, you’re increasing your risk exposure – daily.”

– Michael Elliott, Atrium Research & Consulting

Protect Intellectual Property from its Earliest Stage

To accelerate their products’ time-to-market, R&D-driven organizations must use the latest laboratory automation technologies while protecting vital intellectual property and trade secrets. Also, they must meet current and emerging regulatory requirements. Therefore, it is critical for companies to guarantee that the documents supporting their intellectual property and trade secrets are authentic and legally verifiable.

In R&D departments, laboratory notebooks are typically used to collect data, record experiments and prove ownership of an invention or trade secret. Electronic lab notebooks have penetrated over 20% of all biopharmaceutical companies. “To ensure the trustworthiness of electronic records, effective management controls must be in place to guarantee their timing, integrity, and authenticity,” said Michael Elliott, President of Atrium Research and Consulting. “One must not only secure data against theft or alteration, but be able to prove when the record was created, who created it, who approved/signed it, detection of any changes, and an auditable trail of the record’s lifecycle.”

Astra Zeneca uses electronic lab notebooks and other lab automation technologies to capture and share the valuable scientific data and intellectual property produced by their chemists. To ensure the trustworthiness of electronic records, track the date and time of a document's creation, and demonstrate that archived R&D records are authentic and tamperproof over a period of months, years or even decades, they use AbsoluteProof®.

Learn more about the importance of record integrity and authentication for electronic R&D

Quick Links

Next Steps